The Pathogenesis of African Trypanosomiasis.
Pays E, Radwanska M, Magez S.
Annu Rev Pathol. 2023 Jan 24;18:19-45. doi: 10.1146/annurev-pathmechdis-031621-025153. Epub 2022 Sep 2.
Human African trypanosomiasis.
Lejon V, Lindner AK, Franco JR.
Lancet. 2025 Mar 15;405(10482):937-950. doi: 10.1016/S0140-6736(25)00107-2.
Trypanosomiasis.
Chimelli L, Scaravilli F.
Brain Pathol. 1997 Jan;7(1):599-611. doi: 10.1111/j.1750-3639.1997.tb01077.x.
Second stage human African Trypanosomiasis with Trypanosoma brucei rhodesiense treated with fexinidazole.
Helleberg BB, Gudmundsson KSS, Kurtzhals JAL, Helleberg M.
Lancet Infect Dis. 2023 Nov;23(11):e505. doi: 10.1016/S1473-3099(23)00358-4.
African Trypanosomiasis.
Streit JA, Matsumoto E.
N Engl J Med. 2016 Dec 15;375(24):2380. doi: 10.1056/NEJMicm1604333.
Reemergence of Human African Trypanosomiasis Caused by Trypanosoma brucei rhodesiense, Ethiopia.
Abera A, Mamecha T, Abose E, Bokicho B, Ashole A, Bishaw T, Mariyo A, Bogale B, Terefe H, Tadesse H, Belachew M, Difabachew H, Eukubay A, Kinde S, Ali A, Regasa F, Seife F, Kebede Z, Wossen M, Tollera G, Hailu M, Manaye N, Van Reet N, Priotto G, van Griensven J, Pareyn M, Tasew G.
Emerg Infect Dis. 2024 Jan;30(1):125-128. doi: 10.3201/eid3001.231319. Epub 2023 Nov 15.
Human African trypanosomiasis.
Lejon V, Bentivoglio M, Franco JR.
Handb Clin Neurol. 2013;114:169-81. doi: 10.1016/B978-0-444-53490-3.00011-X.
African trypanosomiasis.
Maudlin I.
Ann Trop Med Parasitol. 2006 Dec;100(8):679-701. doi: 10.1179/136485906X112211.
Human African Trypanosomiasis: Progress and Stagnation.
Bottieau E, Clerinx J.
Infect Dis Clin North Am. 2019 Mar;33(1):61-77. doi: 10.1016/j.idc.2018.10.003.
Hybrid-Compounds Against Trypanosomiases.
Nunes JA, Ferreira da Silva-Júnior E.
Curr Drug Targets. 2022;23(14):1319-1329. doi: 10.2174/1389450123666220509202352.
